Development and external validation of a new prognostic model for metastatic clear cell renal cell carcinoma: a preregistered analysis using data from randomised clinical trials in the checkpoint inhibitor era.

Yervoy (ipilimumab) - BMS

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

Cabometyx (cabozantinib tablet) - Exelixis

sunitinib - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/42716079

Anke Richters; Axel Bex; Berna C Özdemir; Hans M Westgeest; Johanna A A Damen; Katja K H Aben; Marinde J G Bond

Sep 10, 2026